ArticleEuropean journal of nuclear medicine and molecular imaging2024
Targeted interleukin-2 enhances the in vivo anti-cancer activity of Pluvicto™.
Tony Georgiev et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this paperpooled itcites it